NMS-019 - Novel Triazole linked thymol-thienopyrimidine hybrids: In vitro and in silico studies

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: NMS-019
• By: ATEşOğLU, Şeyma (BezmiAlem Vakif University, Institute of Health Sciences, Department of Biotechnology, Türkiye)
• Co-author(s): Ms Şeyma Ateşoğlu (BezmiAlem Vakif University, Institute of Health Sciences, Department of Biotechnology, Istanbul, Türkiye / BezmiAlem Vakif University, Faculty of Medicine, Department of Medical Biology, Istanbul, Türkiye)
  Res. Asst. Furkan Çakır (Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul, Türkiye)
  Assoc. Prof. Dr. Aytekin Köse (Aksaray University, Faculty of Science and Letters, Department of Chemistry, Aksaray, Türkiye)
  Prof. Dr. Fahri Akbaş (BezmiAlem Vakif University, Faculty of Medicine, Department of Medical Biology, Istanbul, Türkiye)
  Zeynep Şule Bilgiseven (Faculty of Pharmacy, Istanbul, Türkiye)
  Assoc. Prof. Dr. Halil Şenol (Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul, Türkiye)
  
• Abstract:

  Background Information
  Cancer remains a leading cause of death, with increasing incidence and mortality. By 2030, cancer cases are expected to reach 21 million annually. The need for novel agents with improved efficacy and fewer side effects is urgent. Natural products play a crucial role in drug discovery, particularly in oncology. Hybrid..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login